121 growth-stage healthtech investors in the US

Top 5 growth-stage healthtech investors in the US, ranked by recent fund activity

Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (30: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (20; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (12) and completeness of the public record (8). Stage and regional focus are our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.

1. Town Hall Ventures

   Type: VC firm · HQ: New York, NY · Stages: Growth · Focus: Healthtech, Impact, Medtech · Latest activity: New deal, Sep 2026 · Fund size on file: $400M (SEC Form D, 2025)

   Dated new deal in Sep 2026; $400M fund on file (SEC Form D, 2025); states healthtech and digital health as a focus; backs growth-stage; names the US as where it invests; 8 named decision-makers on file.

2. Longitude Venture Partners

   Type: VC firm · HQ: Menlo Park, CA · Stages: Growth · Focus: Healthtech, Biotech, Medtech · Latest activity: New deal, Jun 2026 · Fund size on file: $600M (SEC Form D, 2022)

   Dated new deal in Jun 2026; $600M fund on file (SEC Form D, 2022); states healthtech and digital health as a focus; backs growth-stage; names the US as where it invests; 8 named decision-makers on file.

3. MVM Partners LLP

   Type: VC firm · HQ: Boston, MA · Stages: Growth · Focus: Healthtech, Biotech, Medtech · Latest activity: Portfolio news, Jun 2026 · Private fund assets: $1.0B (SEC Form ADV)

   Portfolio news dated Jun 2026; $1.0B on file (SEC Form ADV); states healthtech and digital health as a focus; backs growth-stage; names the US as where it invests.

4. Alpha Partners

   Type: VC firm · HQ: New York, NY · Stages: Series B, Growth · Focus: Healthtech, AI, Developer Tools, Cybersecurity · Latest activity: New fund, Oct 2026 · Fund size on file: $200M (SEC Form D, 2024)

   Latest fund filing dated Oct 2026; $200M fund on file (SEC Form D, 2024); states healthtech and digital health as a focus; backs Series B, growth-stage; names the US as where it invests; 8 named decision-makers on file.

5. Elsewhere Partners

   Type: VC firm · HQ: Austin, TX · Stages: Growth · Focus: Healthtech, Cybersecurity, AI, SaaS · Latest activity: New deal, Jul 2026 · Fund size on file: $285M (SEC Form D, 2023)

   Dated new deal in Jul 2026; $285M fund on file (SEC Form D, 2023); states healthtech and digital health as a focus; backs growth-stage; names the US as where it invests; 8 named decision-makers on file.

First 25 of 121 growth-stage healthtech investors in the US

You are seeing 25 of 121. The full list adds 96 more investors and 679 named decision-makers.

How these 121 break down

Questions

Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to healthtech and digital health, growth-stage and the US. Guide: how to find investors for a healthtech and digital health startup. Markdown version of this page.